000 | 01053 a2200301 4500 | ||
---|---|---|---|
005 | 20250513155600.0 | ||
264 | 0 | _c19990211 | |
008 | 199902s 0 0 eng d | ||
022 | _a0085-2538 | ||
024 | 7 |
_a10.1046/j.1523-1755.1998.001711.x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aFogo, A B | |
245 | 0 | 0 |
_aCompound interest: ACE and PAI-1 polymorphisms and risk of thrombosis and fibrosis. _h[electronic resource] |
260 |
_bKidney international _cNov 1998 |
||
300 |
_a1765-6 p. _bdigital |
||
500 | _aPublication Type: Editorial | ||
650 | 0 | 4 | _aFibrosis |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aPeptidyl-Dipeptidase A _xgenetics |
650 | 0 | 4 |
_aPlasminogen Activator Inhibitor 1 _xgenetics |
650 | 0 | 4 | _aPolymorphism, Genetic |
650 | 0 | 4 |
_aRenin-Angiotensin System _xphysiology |
650 | 0 | 4 | _aRisk |
650 | 0 | 4 |
_aThrombosis _xetiology |
700 | 1 | _aVaughan, D E | |
773 | 0 |
_tKidney international _gvol. 54 _gno. 5 _gp. 1765-6 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1046/j.1523-1755.1998.001711.x _zAvailable from publisher's website |
999 |
_c9807329 _d9807329 |